Renal Cell Carcinoma

Clinical Management

  • Steven C. Campbell
  • Brian I. Rini

Part of the Current Clinical Urology book series (CCU)

Table of contents

  1. Front Matter
    Pages i-xi
  2. Localized Disease

    1. Front Matter
      Pages 1-1
    2. Frédéric D. Birkhäuser, Nils Kroeger, Allan J. Pantuck
      Pages 3-22
    3. Ming Zhou, Huiying He
      Pages 23-41
    4. Simon P. Kim, Bradley C. Leibovich
      Pages 43-52
    5. Andrei S. Purysko, Erick M. Remer, Brian R. Herts
      Pages 53-82
  3. Management of Localized RCC

    1. Front Matter
      Pages 103-103
    2. Alon Z. Weizer, Jeffery S. Montgomery, Khaled S. Hafez
      Pages 133-153
    3. Surena F. Matin, Kamran Ahrar
      Pages 155-166
    4. Marc C. Smaldone, Daniel Canter, Alexander Kutikov, Robert G. Uzzo
      Pages 167-194
  4. Locally Advanced Disease

    1. Front Matter
      Pages 195-195
    2. Stephen H. Culp, Christopher G. Wood
      Pages 197-218
    3. Sean P. Stroup, Ithaar H. Derweesh
      Pages 219-228
  5. Advanced Disease

    1. Front Matter
      Pages 229-229
    2. Michael M. Vickers, Daniel Y. C. Heng
      Pages 249-255
    3. Tom Powles, Axel Bex
      Pages 257-277
    4. Diwakar Davar, Moon Fenton, Leonard J. Appleman
      Pages 279-301
    5. Linda Cerbone, Cora N. Sternberg
      Pages 303-315
    6. Eric Jonasch, Michel Choueiri
      Pages 317-337
    7. Armida Parala-Metz, Mellar Davis
      Pages 339-348
  6. Back Matter
    Pages 349-362

About this book


Renal Cell Carcinoma: Clinical Management provides a comprehensive, state-of-the art review of this field, and will serve as a valuable resource for clinicians, surgeons and researchers with an interest in kidney cancer. The volume reviews new data about risk factors for the disease, profiles the new staging system for renal cell carcinoma (RCC), highlights our current understanding of familial syndromes of RCC and their molecular genetics, and provides new perspectives about imaging of renal tumors. For localized disease, a greater appreciation of nephron-sparing approaches and the importance of preservation of renal function is discussed in detail. Advances in surgical techniques are highlighted. For metastatic disease, the molecular biology of kidney cancer is reviewed in a concise and understandable manner, including the data that has fostered novel targeted approaches that have revolutionized management. The several landmark phase III targeted therapy trials published in the last few years are placed in context with respect to current management.


Familial RCC Multiplanar CT RAD Nx Radiographic imaging Targeted therapy Thermal ablation cT1 renal tumors

Editors and affiliations

  • Steven C. Campbell
    • 1
  • Brian I. Rini
    • 2
  1. 1.Glickman Urological and Kidney InstituteCenter for Urologic OncologyClevelandUSA
  2. 2.College of Medicine, Case Western Reserve UniversityCleveland Clinic LernerClevelandUSA

Bibliographic information

  • DOI
  • Copyright Information Springer Science+Business Media New York 2013
  • Publisher Name Humana Press, Totowa, NJ
  • eBook Packages Medicine
  • Print ISBN 978-1-62703-061-8
  • Online ISBN 978-1-62703-062-5
  • Buy this book on publisher's site